Method and apparatus for the delivery of substances to biological components

• US 20050075620A1
• Filed: 01/22/2002
• Published: 04/07/2005
• Est. Priority Date: 01/26/2001
• Status: Abandoned Application

• Current Assignee: Yoni Iger
• Original Assignee: Yoni Iger
• Inventors: Iger, Yoni
• Application Number:
  US10/466,796
• Publication Number:
  US 20050075620A1
• Time in Patent Office: Days
• US Class Current: 604/500
• CPC Class Codes: A61B 1/313 for introducing through surgical openings, e.g. laparoscopes
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
• CPC Class Codes: A61M 5/30 Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules

Abstract

The invention concerns a method and device for needle-less delivery of substances into or through natural or artificial biological components such as membranes, organelles, cells, tissues, organs, or creatures, by exposing the said biological components to accelerated substances wherein high impact mechanical movement over short distance is used to create acceleration of substances so to drive substances into or through said natural or artificial biological components, while isolating the biological component from the driving force. The mechanical movement is preferably created by an ultrasonic member having a high repetition rate, and the space between accelerating element and biological target is preferably composed of low density compound. The delivery device can be provided with a unit for supplying substance to be delivered, to the mechanical accelerating element. The device can be constructed either as delivery device for superficial tissues, or as an endoscopes laparoscope-like or catheter-like device for delivery in minimally invasive procedures.

Claims

1. A method for the administration of substances to and/or through biological components, comprising exposing the substance to be delivered to a cyclic high impact accelerating movement over a short displacement of amplitude, causing acceleration of the substance, rapid displacement of the substance and driving the substance to and/or through biological components, while isolating the bulk of the targeted biological components from the driving force during delivery.

2. A method according to claim 1, wherein the biological components include membranes, organelles, cells, tissues, organs, biological vectors, creatures or artificial biological components including implants and encapsulated cells.

3. A method according to claim 1, wherein the frequency of the cyclic stimulus is at least 1 Hz.

4. A method according to claim 3, wherein the cyclic stimulus is performed by means capable of performing such cyclic movement stimulus.

5. A method according to claim 4, wherein the stimulus is emitted by ultrasound member and delivery is performed by accelerating substance attached to ultrasonic vibrating element.

6. A method according to claim 5, wherein the ultrasound emitting device is composed of piezoelectric crystals.

7. A method according to claim 3, wherein the frequency of the stimulus is 10 Hz to 30 MHz.

8. A method according to claim 7, wherein the frequency of the stimulus is 10 kHz to 3 MHz.

9. A method according to claim 8, wherein the frequency of the stimulus is 20 kHz to 100 kHz.

10. A method according to claim 1, wherein the accelerating movement is for a time period equivalent to at least a quarter of a cycle and at least one stimulus is being given, wherein the substance to be administered is coupled to the stimulating element during at least part of the stimulus period and essentially till desired delivery is carried out.

11. A method according to claim 1, wherein the displacement amplitude is 1 micron to 10,000 microns.

12. A method according to claims 11, wherein the displacement amplitude is 20 microns to 200 microns.

13. A method according to claim 1, wherein the intensity of the stimulus is 0.0001 W/cm² to 10,000 W/cm².

14. A method according to claim 13, wherein the intensity of the stimulus is 0.1 W/Cm² to 100 W/Cm².

15. A method according to claim 14, wherein the intensity of the stimulus is 3 W/cm² to 50 W/cm².

16. The method of claim 1, wherein during delivery a distance exists between the accelerating substance to be delivered and biological component.

17. A method according to claim 16, wherein the space at the distance between accelerating substance to be delivered and biological component, the space through which delivery is performed, is composed of low density medium.

18. A method according to claim 17, wherein the low density medium is gas.

19. A method according to claim 18, wherein reduction of the gas atmospheric pressure is induced in space between substance to be delivered and biological component.

20. The method of claim 19, wherein reduction of the gas pressure is performed by suction.

21. A method according to claim 1, wherein the accelerated substances are delivered without essentially causing any irreversible damage to the bulk of said biological components.

22. A method according to claim 1, wherein the accelerated substances are delivered while causing damage to the superficial zone of biological components.

23. A method according to claim 22, wherein damage is performed to epithelial tissues, which might be moist or keratinized epithelial tissues.

24. A method according to claim 23, wherein damage is utilized for removal of layers of cells or extra cellular matrix.

25. A method according to claim 1, wherein delivered substances are adhered to biological component surface, causing paving-like effect.

26. A method according to claim 1, wherein the accelerated substances are delivered and subsequently within a time period in which at least a portion of said substances remain in biological component target, a controlled damage is caused to at least part of the biological components.

27. A method according to claim 1, used for therapeutic and cosmetic purposes, as well as for diagnostic and experimental purposes, according to the type of substance to be delivered, and the relevant biological component.

28. A method according to claim 27 wherein delivered substances are active agents used for treatment, prevention including active or passive vaccination, creating toxic effect or controlled degeneration by themselves or after activation, initiation or cessation of processes, being substrate elements or resources for procedures, reduction or acceleration of processes, reduction the tension of muscles for instance, sedation or local anesthesia, changing mechanical or chemical properties, giving mechanical support, paving, adding or removing active components, performing genetic manipulations or gene therapy, fertilization, carrying other substances, slow release, staining or marking and the like.

29. A method according to claim 27, wherein delivered substances are essentially inert compounds.

30. A method of claim 27, wherein the substance to be delivered is present in appropriate medium that might be liquid, gel, paste, powder, pellet, solid strip, sleeve and the like.

31. A method of claim 27, wherein the substance require further activation after being delivered.

32. The method of claim 27, wherein the compounds to be administered are soluble.

33. The method of claim 27, wherein the compounds to be administered are complex particles.

34. A method according to claim 33, wherein the complex particles are particles affecting chemical, physiological, or mechanical properties of biological component, wherein particles are essentially selected from the following groups consisting of:

Particles impregnated with sedation, tension removal or anti ageing agents, medicaments including radio-active compounds, nutrients, gene-therapy compounds;

Particles impregnated with compounds that shall be further activated;

Particles having particular coat which might be protective, Particles capable of slow release;

Plasmids or other biological or non biological carriers or vectors;

Nano-machines, Particles which are biological components such as nucleus, bacteria, viruses or virions, fungi, protozoa, parasites or their fragments.

35. A method according to claim 33 wherein the complex particles are inert particles.

36. A method according to claim 27, wherein more than one substance is delivered to biological compound.

37. A method according to claim 36, wherein different substances are delivered under different acceleration parameters.

38. A method according to claim 36, wherein different substances are delivered under same delivery regime.

39. A method according to claim 1, wherein the delivery is the main treatment.

40. A method according to claim 1, wherein pre-treatment is applied to the biological component before delivery.

41. A method according to claim 40, wherein the delivery method of the present invention is used as pre-treatment method.

42. A method according to claim 1, wherein post-treatment is applied to the biological component after delivery.

43. A method according to claim 42, wherein the delivery method of the present invention is used as post treatment method.

44. A method according to claim 1, wherein the delivery method composed at least part of the steps of any of pre-treatment, treatment, or post treatment, and any combination thereof.

45. A method according to claim 44, wherein at least part of the steps are carried out simultaneously.

46. A method according to claim 44, wherein at least part of the steps are carried out in subsequent order.

47. A method according to claim 1, wherein delivery is performed as stand alone procedure.

48. A method according to claim 1, wherein acceleration element of this invention is accommodated in another housing capable of delivery, to enhance delivery of said another housing while working in combined mode.

49. A method according to claim 48, wherein another housing capable of delivery is gas spring actuating jet injector.

50. A device and a system for use in the method of any one of the preceding claims.

51. A device and a system according to claim 50, substantially as hereinbefore described.

53. A system according to claim 51 containing also means for supply of substance to be delivered to site of acceleration, so to be delivered.

54. A system according to claim 51 containing means for transmitting the acceleration element to the substance.

55. A system according to claim 51, wherein space exists between substance to be delivered and biological component.

56. A system according to claim 55 comprising also means for reduction of the density of material in space between substance to be delivered and biological components

57. A system according to claim 56 whereas means are composed of suction element for removing components and for the reduction of the atmospheric pressure in said space between substance to be delivered and biological component

58. A system according to claim 51 wherein the acceleration agent is comprised of an element capable of emitting ultrasound waves and the system generally comprises power source, control unit, a signal generator, a signal amplifier, a matching unit, at least one transducer capable of emitting ultrasonic waves, and substance.

59. A system according to claim 58 wherein wave-guide exists between the emitting element and the substance to be delivered.

60. A system according to claim 59 wherein said wave-guide amplifies amplitude of vibration, therefore amplifies acceleration rate.

61. A system according to claim 60 wherein wave-guide oscillates at resonance.

62. A system according to claim 59 wherein substance to be delivered composed at least portion of the wave-guide.

63. A system according to claim 51 containing housing encasing at least portion of accelerating element and at least portion of substance to be delivered.

64. A system according to claim 63 wherein housing is attached to affect biological component, using attachment means.

65. A system according to claim 64 wherein said housing is a hand held device.

66. A system according to claim 51 wherein system includes invasive agents such as laparoscope element or catheter.

67. A system according to claim 58 comprising also a reflector for reflecting and changing direction of ultrasonic irradiation.

71. A system according to claim 51, wherein delivery device of this invention is attached to, or composed part of, another housing capable of delivery to enhance performance of said another housing.

72. A system according to claim 71, wherein another housing is gas spring actuating jet injector.

52. A device for the administration by acceleration of substances to and/or through biological components comprising:

at least one acceleration agent capable of giving acceleration stimulus and at least a portion of substance to be delivered.

68. A system according to claim 52 wherein surface of accelerating agent is flat.

69. A system according to claim 68 wherein surface of accelerating agent is shaped otherwise.

70. A system according to claim 52 wherein surface of accelerating agent is covered by compounds capable of reducing the surface tension, therefore enabling easy release of substance to be delivered.

73. A system and method as hereinabove described for the treatment of non-biological components.